CLL: Treatment and Management Strategies for Best Outcomes - Episode 9

Venetoclax-Based Treatment Clinical Trial Updates

May 22, 2024
Yuliya P.L Linhares, MD

,
Josie Montegaard, MSN, AGPCNP-BC

Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.

EP. 1: Understanding a CLL Diagnosis
EP. 2: Diagnostic Tests in CLL
EP. 3: Goals of Treatment for Patients With CLL
EP. 4: Current First-Line Treatment Options in CLL
EP. 5: Factors That Guide CLL Treatment Decisions
EP. 6: What to Expect from Treatment
EP. 7: Overview of Efficacy and Safety Data for Current CLL Treatment Options
EP. 8: Acalabrutinib-Based Treatment Clinical Trial Updates
Now Viewing
EP. 9: Venetoclax-Based Treatment Clinical Trial Updates
EP. 10: Zanubrutinib-Based Treatment Clinical Trial Updates
EP. 11: Ibrutinib-Based Treatment Clinical Trial Updates
EP. 12: Newer Combinations for the Treatment of CLL
EP. 13: What to Know Before Starting Your CLL Treatment
EP. 14: An Overview of Potential Treatment Adverse Effects
EP. 15: Treatment Decisions in R/R CLL
EP. 16: Shared Decision-Making and Supportive Care in the CLL Treatment Journey
EP. 17: Optimizing Overall Health During CLL Management
EP. 18: Getting the Most From Your CLL Care Team

Related Content:

CLL: Treatment and Management Strategies for Best OutcomesBaptist Health Cancer CareDana-FarberCLLCURE Expert Connections
How FDA-Approved Modeyso Works to Treat Glioma
How Can We Stand Up to Cancer as Patients?
FDA Approval of Modeyso For Glioma May Lead to Combination Therapies